Evidence mapPaperPMID 37043974Full record

Observational studyAtencion primaria2023

[Metabolic morbidity in the prison population of Catalonia, Spain].

Andrés Marco Mouriño, Jesús Rivera-Esteban, Salvador Augustin, Elisabet Turu Santigosa, Juan M Pericàs, FatPrison Study Group

Open access · goldAbstract readObservational StudyEnglish Abstract
In one paragraph

Observational study in Atencion primaria, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Andrés Marco MouriñoPrograma de Salud Penitenciaria, Instituto Catalán de la Salud, Catalunya, España; CIBER de Epidemiologia y Salud Pública (CIBERESP), Madrid, España. Electronic address: amarco@gencat.cat.
Jesús Rivera-EstebanUnidad Hepática, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut of Reseach (VHIR), Universitat Autònoma de Barcelona, Barcelona, España.
Salvador AugustinUnidad Hepática, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut of Reseach (VHIR), Universitat Autònoma de Barcelona, Barcelona, España.
Elisabet Turu SantigosaPrograma de Salud Penitenciaria, Instituto Catalán de la Salud, Catalunya, España.
Juan M PericàsUnidad Hepática, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut of Reseach (VHIR), Universitat Autònoma de Barcelona, Barcelona, España; CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd), ISCIII, Madrid, España.
FatPrison Study Group
Vall d'Hebron Institut de Recerca · ESCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESInstituto Nacional de la Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the prevalence of metabolic morbidity (MM) amongst prison inmates.

designMulticentric, cross-sectional observational study.

settingAll (nine) prisons in Catalonia.

participantsConvicted inmates that are not in an «open regime», whose healthcare relies on the Prison Primary Care Teams.

interventionsMM was defined as the presence of at least one component of the metabolic syndrome, i.e., obesity, arterial hypertension, type2 diabetes, and/or dyslipidemia. The variables collected included anthropometric measurements, medical history and laboratory values related to MM. The source of information was the Catalan Primary Healthcare Services Information System (SISAP). MAIN MEASUREMENTS: The prevalence of MM, overall and by several participant subcategories, was calculated. To investigate the risk factors associated to a higher prevalence of MM, a multivariable logistic regression analysis was carried out and expressed as adjusted odds ratios and 95% confidence intervals.

results4338 inmates were studied, of whom 93.9% were male. Mean age was 38.4years, 51.7% were born in European Union countries, and 6.7% were infected by HIV. The variables associated with a significantly increased risk of presenting MM were older age and HIV infection, whereas certain geographical origins (i.e., non-UE European countries, Maghreb and Sub-Saharan Africa) were associated with lower risk of MM.

conclusionsIn spite of being an overall young population, prison inmates present high rates of MM. Older age, HIV infection and geographic origin appear as the most strongly associated factors with MM in the prison population. MM should be detected early in order to prevent complications. Prevention, screening and treatment of MM ought to be considered a priority in the clinical routine of prison healthcare professionals.

Indexed as

HIV InfectionsAdultCross-Sectional StudiesFemaleHumansMaleMorbidityPrevalencePrisonsSpainEnfermedades no transmisiblesEpidemiologíaEpidemiologyMetabolic syndromeNon-communicable diseasesPrisionesPrisonsSíndrome metabólico

Identifiers

PMID37043974
PMCPMC10119707
OpenAlexW4362734067

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.